More about ARA-290 (16mg)
ARA-290, also known as cibinetide, is a synthetic peptide supplied exclusively for controlled laboratory, analytical, and in vitro research. It may be used in experimental systems examining peptide characterization, receptor-binding behavior, molecular recognition, and associated signaling mechanisms.
ARA-290 is provided as a lyophilized research material. References to biological pathways describe areas of scientific investigation only and do not indicate an approved clinical, therapeutic, veterinary, or consumer application.
ARA-290 (16mg) – Research Specifications:
| Compound |
ARA-290 |
| Alternate Name |
Cibinetide |
| Quantity |
16mg per vial |
| Compound Type |
Synthetic peptide research material |
| Sequence |
pEQLERALNSS |
| Molecular Formula |
C51H84N16O21 |
| Molecular Weight |
Approximately 1,257.4 g/mol |
| CAS Number |
1208243-50-8 |
| Appearance |
Lyophilized peptide powder |
| Purity / Identity |
Refer to the lot-specific Certificate of Analysis for analytical verification |
| Analytical Documentation |
Batch-specific Certificate of Analysis available |
| Storage Conditions |
Store sealed in a cool, dry environment protected from heat, light, and moisture |
| Research Use Only |
Not for human or animal consumption |
What Is ARA-290? Research Background
ARA-290 is an 11-amino-acid synthetic peptide derived from a defined region of the erythropoietin molecule. Its established sequence allows researchers to examine peptide identity, stability, binding characteristics, and molecular activity within controlled experimental systems.
Laboratory investigation of ARA-290 may include analytical method development, peptide characterization, receptor-binding assays, and evaluation of associated molecular signaling under defined conditions. These applications are restricted to controlled scientific research and do not establish safety, efficacy, or suitability for a clinical or consumer purpose.
Experimental findings involving research peptides can vary according to the assay system, material concentration, controls, analytical methods, and other protocol-specific variables. Researchers should independently establish suitable procedures and acceptance criteria for each study.
Important Research Notice: Nordsci research materials are accompanied by lot-specific analytical documentation. Certificates of Analysis are available for laboratories requiring verification of compound identity and analytical characteristics.
THIS PRODUCT IS INTENDED FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR VETERINARY, DIAGNOSTIC, THERAPEUTIC, FOOD, COSMETIC, OR DIETARY SUPPLEMENT USE.
ARA-290 – Key Research Applications
1. Tissue-Protective Signaling Research
ARA-290 may be evaluated in controlled experimental models designed to characterize receptor-associated signaling pathways described in scientific literature. Research may involve binding assays, pathway analysis, and comparisons using appropriate experimental controls.
2. Inflammatory Signaling Studies
Laboratory models may use ARA-290 as a reference material when examining biochemical signaling under experimentally induced inflammatory conditions. These studies are conducted to characterize molecular activity and pathway behavior within defined research systems.
3. Cellular Stress Response Research
ARA-290 may be included in in vitro experiments examining the behavior of selected molecular pathways under controlled cellular stress conditions. Study design should account for assay configuration, baseline conditions, exposure parameters, and analytical endpoints.
4. Cellular Repair Pathway Investigation
Researchers may examine ARA-290 in laboratory models involving molecular pathways associated with experimentally induced cellular responses. These investigations concern pathway characterization and do not imply a medical, restorative, or therapeutic application.
Handling and Research Use Considerations
ARA-290 (16mg) should be handled only by qualified laboratory personnel using appropriate personal protective equipment, documented procedures, and controlled research environments. Laboratories should maintain records of lot numbers, storage conditions, preparation variables, and analytical methods to facilitate material traceability and experimental reproducibility.
Protocol Design Considerations: Experimental findings may be affected by assay configuration, material concentration, sample preparation, environmental conditions, control selection, instrumentation, and analytical methodology. Researchers are responsible for establishing protocols appropriate to their facilities and laboratory objectives.
Nordsci Peptides does not provide instructions concerning dosing, administration, injection, ingestion, topical application, veterinary use, or other in vivo use.
This information is provided exclusively for laboratory research reference. All procedures must be conducted by qualified personnel in accordance with applicable institutional policies, laboratory standards, and regulatory requirements.
ARA-290 (16mg) – Certificate of Analysis (COA)
Lot-specific Certificates of Analysis are available for ARA-290 supplied by Nordsci Peptides. The applicable COA provides analytical information associated with the tested lot and facilitates laboratory identity review, documentation, and material traceability.
Researchers should consult the Certificate of Analysis corresponding to the lot number printed on the product label. Analytical documentation applies only to the identified lot and should not be interpreted as evidence of clinical safety, therapeutic effectiveness, or suitability for human or animal use.
Where to Buy ARA-290 for Research
Nordsci Peptides supplies ARA-290 (16mg) as a research-grade synthetic peptide for qualified laboratory and analytical use. Each vial is packaged as a lyophilized research material, with lot-specific analytical documentation available for identity and quality review.
IMPORTANT: ARA-290 (16mg) is sold exclusively as a laboratory research material. It is not approved for human or animal consumption and is not intended for veterinary, diagnostic, therapeutic, food, cosmetic, or dietary supplement use. Purchasers are responsible for complying with all applicable laws, institutional policies, and laboratory requirements.
Scientific References
- Brines M, et al. Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proceedings of the National Academy of Sciences.
- Brines M, Cerami A. The receptor that tames the innate immune response. Molecular Medicine.
- Research concerning erythropoietin-derived peptides and receptor-associated molecular signaling.
- Lot-specific analytical documentation available through the Nordsci Peptides COA Library.